Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Marex Group Limited Ordinary Shares (MRX) vs Smith & Nephew plc (SNN) Price & Performance

Marex Group Limited Ordinary SharesTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Marex Group Limited Ordinary Shares vs Smith & Nephew plc — how do they compare? Marex Group Limited Ordinary Shares trades at $71.17 (market cap $5.12B), while Smith & Nephew plc trades at $27.23 (market cap $11.10B). The key difference: Smith & Nephew plc is far larger — about 2.2× Marex Group Limited Ordinary Shares's market cap, and Smith & Nephew plc pays the higher dividend (2.95%). Which is the better fit depends on your goals — on Pluang, investors hold Marex Group Limited Ordinary Shares for 0 Days and Smith & Nephew plc for 120 Days on average.

MRXSNN
Market Cap
$5.12B$11.10B
Volume
647,3701,051,703
Sector
FinancialsHealth
52-Week High
$78.27$37.17
52-Week Low
$29.92$26.42
Typical Hold Time
0 Days120 Days
Enterprise Value
$8.20B$14.13B
Dividend Yield
0.9%2.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Marex Group Limited Ordinary Shares

No Aura AI signal available yet.

Smith & Nephew plc

Smith & Nephew (SNN) trades at $26.89, near its 52-week low, with a bearish technical signal. Revenue grew to $6.16B in 2025, with net income margin improving to 10.08%. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio, though the stock faces headwinds from analyst downgrades and CFO departure news.

The outlook is cautious; while fundamentals show profitability growth, the stock's proximity to lows and mixed analyst sentiment (26% buy, 65% hold) suggest limited near-term upside. Key risks include competitive pressures and execution challenges, but the stable dividend and institutional interest offer some support for patient investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MRX
100% Buy0% Sell
Avg holding period · 0 Days
SNN

No sentiment data available yet.

About Marex Group Limited Ordinary Shares

Marex Group provides financial services across commodities, financial markets, and corporate clients. Its services include clearing, agency and execution, market making, hedging, and securities services.

Read more on MRX →

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN →